InvestorsObserver is giving SpringWorks Therapeutics Inc (SWTX) an Analyst Rating Rank of 74, meaning SWTX is ranked higher by analysts than 74% of stocks. The average price target for SWTX is $114.75 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating SWTX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SWTX!